Loading...
Loading...
A report from Goldman Sachs reiterates its Neutral rating on D.R. Horton
DHI.
The report states, “The majority of DR Horton's 4QFY11 results were in line; however, the EPS miss was driven primarily by a 70 bp margin shortfall. One offsetting positive is the minimal 4Q writedowns for a company that has historically taken much larger seasonal impairments. We believe that most builders are at the end of their inventory writedown cycle, absent a major step down in home prices.”
DHI closed yesterday at $11.66.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in